4 results
Primary Objectives:*Phase 0: To determine the receptor occupancy of OPN-305 1.5mg/kg in patients receiving an ECD, DCD or SCD(CIT>18h) kidney transplantation and to verify the doses of OPN-305 to be used in Part A of the study.*Part A: to…
This study is designed as a single-center diagnostic accuracy study. The duration of the study is 2 years. To introduce tissue sensing during the stereotactic VABB, we developed an optical introducer with DRS fibers that can be integrated with the…
Primary :• To evaluate the safety and tolerability of blinatumomab incombination with AMG 404 in adults with R/R B-ALL• To estimate the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of AMG 404 when combined with cIV…
This study consists of two phases. The first phase includes a pilot study for the feasibility of using this new developed smart VAE device. If this pilot study is successful we will continue to the second phase. This phase includes a proof of…